CRL Charles River Laboratories International, Inc.

NYSE
$278.26

Charles River Laboratories International, Inc. (CRL) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bearish Selling ran elevated versus CRL's own trailing one-year pace, with 93% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 6 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
6
18 transactions
Purchases
$0
0 shares
Sales
$42.6M
165,990 shares
Net activity
-$42.6M
purchases less sales

How much of that selling was preplanned? 93% planned / 7% discretionary

10b5-1 plan sales $39.6M 7 transactions · 154,593 shares
Discretionary sales $3.0M 11 transactions · 11,397 shares

Largest single sale: $16.9M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: March 3, 2026 , by LaPlume Joseph W .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
FOSTER JAMES C Director Sell 10b5-1 33,561 $300.00 $10.1M 31,596 −51.5% of holding
Parisotto Shannon M CEVP, Disc & Safety Assessment Sell 10b5-1 2,039 $294.12 $599.7K 4,807 −29.8% of holding
Andrews Nancy C Director Sell 573 $285.24 $163.4K 1,438 −28.5% of holding
Girshick Birgit Chief Executive Officer Sell 10b5-1 6,500 $279.90 $1.8M 36,013 −15.3% of holding
Parisotto Shannon M CEVP, Disc & Safety Assessment Sell 10b5-1 3,714 $279.66 $1.0M 4,807 −43.6% of holding
FOSTER JAMES C Director Sell 10b5-1 28,733 $275.00 $7.9M 31,596 −47.6% of holding
Knell Michael Gunnar 9 fills SVP, Finance and CAO Sell 6,645 $260.38 $1.7M 14,878 −30.9% of holding
Creamer Victoria L EVP & Chief People Officer Sell 4,179 $259.16 $1.1M 30,051 −12.2% of holding
Parisotto Shannon M CEVP, Disc & Safety Assessment Sell 10b5-1 5,046 $263.00 $1.3M 4,807 −51.2% of holding
FOSTER JAMES C Director Sell 10b5-1 75,000 $225.00 $16.9M 31,596 −70.4% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.